Filter
722
Text search:
quality
assured
medical
products
Featured
Recommendations
86
New Publications
238
Language
Document type
No document type
384
Guidelines
120
Studies & Reports
112
Manuals
48
Strategic & Response Plan
43
Training Material
10
Situation Updates
2
Fact sheets
2
Resource Platforms
1
Countries / Regions
India
38
Global
30
Kenya
23
Nigeria
19
Western and Central Europe
19
Uganda
17
Ethiopia
13
Zambia
13
Ghana
12
Tanzania
11
Myanmar / Burma
11
Nepal
10
Liberia
9
Philippines
9
South–East Asia Region
9
Bangladesh
8
Eastern Europe
8
Malawi
7
Lesotho
7
Africa
7
Sierra Leone
6
Cambodia
6
South Africa
6
Latin America and the Carribbean
6
Ukraine
5
West and Central Africa
5
Asia
5
Burkina Faso
4
Zimbabwe
4
Rwanda
4
Namibia
4
East and Southern Africa
4
Senegal
3
Congo, Democratic Republic of
3
Pakistan
3
Middle East and North Africa
3
Guinea
2
South Sudan
2
Iraq
2
Afghanistan
2
Germany
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Sri Lanka
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Laos
2
Georgia
2
USA
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Jordan
1
Syria
1
Thailand
1
Benin
1
Central African Republic
1
Brazil
1
Switzerland
1
Botswana
1
Libya
1
Guatemala
1
Bhutan
1
Tajikistan
1
Estonia
1
Iran
1
North America
1
Gabon
1
Maldives
1
United Kingdom
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
252
Clinical Guidelines
93
Public Health
47
Pharmacy & Technologies
35
Women & Child Health
29
Key Resources
21
Capacity Building
11
Toolboxes
TB
87
AMR
78
HIV
64
Pharmacy
51
COVID-19
36
NTDs
25
Rapid Response
21
Mental Health
17
Caregiver
12
Ebola
10
Polio
10
Conflict
10
Refugee
10
Global Health Education
10
Disability
9
NCDs
9
Natural Hazards
6
Planetary Health
6
Zika
5
Health Financing Toolbox
3
Specific Hazards
2
Cholera
1
Social Ethics
1
Laboratory diagnosis of Buruli ulcer
recommended
A manual for health care providers.
This manual provides expert guidance on the laboratory techniques and procedures used in the diagnosis of Buruli ulcer, a disease caused by Mycobacterium ulcerans. Aimed at laboratory technicians and scientists working on this disease, the manual details the exac
...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral
...
2nd edition
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei
...
Technical Series on Safer Primary Care
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
NHSP 2017- 2022 (Final draft)
